What the study found
The review argues that metabolic reprogramming in the gut microbiota, meaning changes in how microbes use and process nutrients, may occur before disease appears and may contribute to metabolic diseases in the host. It describes changes in lipid, glucose, amino acid, and uric acid metabolism as part of this process.
Why the authors say this matters
The authors conclude that this framework refines the basic understanding of metabolic disorders and highlights new possibilities for targeting the microbiome in the prevention and treatment of metabolic disorders. The study suggests that understanding microbial metabolic changes may help explain systemic metabolic disease.
What the researchers tested
This is a review article, not an experimental study. The authors introduce the concept of gut microbiota metabolic reprogramming and synthesize existing evidence to build a model linking gut microbiota imbalance, microbial metabolic changes, and host disease.
What worked and what didn't
The review presents a coherent model in which gut microbiota imbalance leads to metabolic reprogramming that affects host metabolic and immune homeostasis. It specifically identifies lipid, glucose, amino acid, and uric acid metabolism as involved pathways, but it does not report original experimental comparisons or quantitative effect sizes.
What to keep in mind
The abstract does not provide details of the review methods, criteria for selecting evidence, or limitations of the synthesis. It also does not present new experimental data, so the claims reflect a proposed framework based on previously reported evidence.
Key points
- The review proposes that gut microbiota metabolic reprogramming may be an early pathogenic event in metabolic disease.
- It links gut microbiota imbalance to changes in lipid, glucose, amino acid, and uric acid metabolism.
- The authors say these microbial changes may influence host metabolic and immune homeostasis.
- The paper is a review article and does not report original experiments.
- The authors suggest the framework may support new microbiome-based prevention and treatment strategies.
Disclosure
- Research title:
- Gut microbiota metabolic reprogramming may contribute to metabolic disease
- Authors:
- Yanrong Wang, Beibei Huang, Xue Wei, Yuanyuan Guan, Lingru Li, Yanfei Zheng, Wenlong Sun
- Institutions:
- Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Shandong University of Technology, Shandong University of Technology, Shandong University of Technology, Shandong University of Technology
- Publication date:
- 2026-03-14
- OpenAlex record:
- View
Get the weekly research newsletter
Stay current with scholarly research without reading academic papers — one filtered digest, every Friday.